ReBuilder Medical Technologies, Inc. Announces its President Featured in Wall Street Reporter Interview

David B. Phillips, Ph.D. Discusses 10% monthly sales growth

Charles Town, WV – August 1, 2007 – ReBuilder Medical Technologies, Inc. (Other OTC: RBRM) announced today that its founder and President, David B. Phillips, Ph.D., was featured in a twenty-minute interview in the Wall Street Reporter (www.wallstreetreporter.com).

Wall Street Reporter, established in 1843, is best known for its exclusive interviews of industry-leading CEO’s and the world’s top investment experts. Through its website, magazines, and conferences, Wall Street Reporter helps smart investors connect with exciting companies. The in depth, unbiased and unfiltered interviews deliver a first-hand, straight-from-the-source perspective which enables investors to make intelligent and informed investment decisions.

David B. Phillips, President of ReBuilder Medical Technologies, Inc., said “We are ecstatic that ReBuilder Medical’s products were featured on an established venue with almost 160 years of editorial experience. It is another example of ReBuilder Medical’s rapid growth and a testament to the products we have introduced into the market.”

About ReBuilder Medical Technologies, Inc.:

ReBuilder Medical Technologies, Inc is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical’s flagship product is its FDA registered ReBuilder System for treating peripheral neuropathy.  Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow. 

ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the Molluscum virus without any side effects.  The company is currently performing research and development on a number of other products as well.

Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located in Charles Town, WV.  He is best known for inventing the very first infrared ear thermometer.  Dr. Phillips also was responsible for the GST System for the early detection of breast cancer and the AcuPen which detects acupuncture points and then treats them.  

More information on ReBuilder Medical and its products can be found at: www.ReBuilderMedical.com

Safe Harbor: This news release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.